Nicoya Health merges with Coya Therapeutics and raises Series A Financing

Client(s) Nicoya Health, Inc.

Jones Day represented Nicoya Health, Inc. in its merger with and into Coya Therapeutics, Inc., and the surviving company's $10 million Series A Preferred Stock financing. Coya Therapeutics, Inc. (formerly Nicoya Health, Inc) is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative and autoimmune diseases.